ArticleJournal of community genetics2026
Characterization of individuals with skeletal dysplasia at a referral center in Brazil.
Article in Journal of community genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comment on "Characterization of individuals with skeletal dysplasia at a referral center in Brazil".Journal of community genetics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skeletal dysplasias are rare genetic disorders affecting bone and cartilage, often causing disproportionate short stature and multisystem involvement. In Brazil, limited data challenge diagnosis and management. To describe the clinical and sociodemographic profile of individuals with suspected skeletal dysplasia, without confirmed etiological diagnosis, evaluated at a university hospital in Salvador, Bahia, Brazil, and referred for genomic sequencing through the Rare Genomes Project. Observational, cross-sectional study including 90 individuals evaluated at Hospital Professor Edgard Santos, that is part of Federal University of Bahia, between December 2020 and May 2023. All patients were evaluated by a medical geneticist, and clinical data were extracted from medical records and standardized using Human Phenotype Ontology (HPO) terms. Most participants (71%) were from countryside of Bahia, 68% were mixed-race, with balanced sex distribution. The mean age was 11.4 years. Consanguinity was reported in 28% and family recurrence in 34% of cases. Among the 15 subgroups listed, the most frequent was "Skeletal dysplasia with decreased bone density" (43.3%). A total of 299 distinct HPO terms reflected high phenotypic variability. This study highlights the clinical heterogeneity of skeletal dysplasia and the importance of a specialized evaluation by a clinical geneticist enabling standardized phenotyping combined with genomic tools to improve diagnosis and public health care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.